...
首页> 外文期刊>Inflammatory bowel diseases >Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health.
【24h】

Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health.

机译:非活动性炎症性肠病患者的功能性胃肠功能紊乱和情绪异常:患病率及其对健康的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Symptoms of functional gastrointestinal disorders (FGID) associated with mood disorders (MD), such as depression and anxiety, occur in some patients with quiescent inflammatory bowel disease (IBD) and could be caused by changes in gut motility, visceral hypersensitivity, or psychological dysfunction. We assessed the prevalence of FGID symptoms and mood disorders in ambulatory patients with quiescent IBD and examined their impact on health-related quality of life (HRQOL) and use of health resources. METHODS: Consecutive ambulatory patients with IBD completed a survey of Rome II criteria for FGID, the Hospital Anxiety and Depression Survey, HRQOL indices, and health resource utilization. Logistic and linear regression analyses tested for predictors of FGID and HRQOL. RESULTS: Of 361 patients surveyed, 149 (44 ulcerative colitis [UC] and 105 Crohn's disease [CD]) had inactive IBD during the previous 12 months. Symptoms of at least 1 FGID occurred in 81.9%. Functional anorectal disorders were the most prevalent (53.7%) followed by functional bowel disorders (51.7%), and both were of greater prevalence than in the Canadian population (41.6% and 22.6%, respectively). Irritable bowel syndrome symptoms were more common in inactive CD than in UC (26% versus 9.1%, P = .01) and functional constipation was more common in inactive UC than in CD (26.2% versus 5.8%, P < .01). MD occurred in 27.3% of UC and 31.3% of CD patients. Age > or =40 years and anxiety independently predicted an FGID. Both FGID symptoms and MD were associated with impaired HRQOL and increased use of health services. CONCLUSIONS: Many patients with inactive IBD have symptoms compatible with FGID. Both FGID-like symptoms and MD are associated with impaired HRQOL and increased health resource utilization. Recognition and treatment of FGID and MD could potentially improve daily functioning of IBD patients.
机译:背景:功能性胃肠道疾病(FGID)的症状与情绪障碍(MD)相关,例如抑郁症和焦虑症,发生在某些静止性炎性肠病(IBD)的患者中,可能是由肠蠕动改变,内脏超敏反应或心理功能障碍。我们评估了静止型IBD的非卧床患者的FGID症状和情绪障碍的患病率,并检查了其对健康相关生活质量(HRQOL)和健康资源使用的影响。方法:连续性IBD的非卧床患者完成了一项针对FGID的罗马II标准,医院焦虑与抑郁调查,HRQOL指数和卫生资源利用的调查。逻辑和线性回归分析测试了FGID和HRQOL的预测因子。结果:在接受调查的361名患者中,有149名(44名溃疡性结肠炎[105]和克罗恩氏病[CD])在过去12个月中无活动性IBD。至少1个FGID的症状发生率为81.9%。功能性肛肠疾病是最普遍的(53.7%),其次是功能性肠病(51.7%),并且两者的患病率均高于加拿大人群(分别为41.6%和22.6%)。在非活动性CD中肠易激综合征的症状比在UC中更为常见(26%比9.1%,P = .01),在非活动性UC中功能性便秘比CD更常见(26.2%对5.8%,P <.01)。 MD发生在UC的27.3%和CD患者的31.3%。年龄大于或等于40岁,焦虑症独立预测出FGID。 FGID症状和MD均与HRQOL受损和卫生服务使用增加有关。结论:许多IBD失活的患者的症状与FGID相适应。像FGID一样的症状和MD均与HRQOL受损和医疗资源利用增加有关。 FGID和MD的识别和治疗可能会改善IBD患者的日常功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号